Suraj Moorthy, PhD, MBA is a senior pharmaceutical insights and strategy leader with more than two decades of experience helping guide specialty drug development, commercialization, and portfolio strategy. As Senior Vice President and Head of Global Strategic Insights at EMD Serono / Merck KGaA, Darmstadt, Germany, he leads global teams that generate evidence-based insights supporting investment decisions across the healthcare product lifecycle—from early-stage development through launch and commercialization. Suraj is recognized for his expertise in forecasting, market research, competitive intelligence, and strategic planning, and is a frequent contributor to industry discussions on the evolving role of insights in pharmaceutical decision-making. He holds a PhD from Duke, and an MBA from the Wharton School of the University of Pennsylvania.
Rare disease launches require fundamentally different approaches, with smaller populations, higher costs and more complex access pathways. Join this session to delve into a range of perspectives on:
• Designing strategies for highly targeted patient populations
• Navigating pricing, access and reimbursement challenges
• Engaging patients, advocacy groups and specialist clinicians
Check out the incredible speaker line-up to see who will be joining Suraj.
Download The Latest Agenda